The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation

Clinical and Laboratory Haematology

Volumn 28, Issue 6, 2006, Pages 382-390

  Schneider, M ^a,b   Munder, M ^a,b,c   Karakhanova, S ^a,b   Ho, A D ^a   Goerner, M ^a,b  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Graft versus host disease; Human; Immunoregulation; Regulatory T cell; Stem cell transplantation

Indexed keywords

ALEMTUZUMAB; CYCLOSPORIN; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; STEROID; TSUKUBAENOLIDE;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; BLOOD; CD4+ CD25+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; STATISTICAL SIGNIFICANCE;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; STEROIDS; T-LYMPHOCYTES, REGULATORY; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750905870     PISSN: 01419854     EISSN: 13652257     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2006.00825.x     Document Type: Article

References (38)

1. +CD25 high regulatory cells in human peripheral blood. Journal of Immunology 167, 1245-1253.
2. Barrat F.J., Cua D.J., Boonstra A., Richards D.F., Crain C., Savelkoul H.F., de Waal-Malefyt R., Coffman R.L., Hawrylowicz C.M. & O'Garra A. (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. Journal of Experimental Medicine 195, 603-616.
3. +CD25high regulatory T cells. Blood 103, 2410-2416.
4. Cohen J.L., Trenado A., Vasey D., Klatzmann D. & Salomon B.L. (2002) CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. Journal of Experimental Medicine 196, 401-406.
5. Curiel T.J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J.R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A., Myers L., Lackner A., Disis M.L., Knutson K.L., Chen L. & Zou W. (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nature Medicine 10, 942-949.
6. Dieckmann D., Plottner H., Berchtold S., Berger T. & Schuler G. (2001) Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood. Journal of Experimental Medicine 193, 1303-1310.
7. Dong X., Bachman L.A., Kumar R. & Griffin M.D. (2003) Generation of antigen-specific, interleukin-10-producing T-cells using dendritic cell stimulation and steroid hormone conditioning. Transplant Immunology 11, 323-333.
8. + regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nature Medicine 9, 1144-1150.
9. Ehrenstein M.R., Evans J.G., Singh A., Moore S., Warnes G., Isenberg D.A. & Mauri C. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNF-alpha therapy. Journal of Experimental Medicine 200, 277-285.
10. + regulatory T cells in patients with Kawasaki disease. Journal of Pediatrics 145, 385-930.
11. Glucksberg H., Storb R., Fefer A., Buckner C.D., Neiman P.E., Clift R.A., Lerner K.G. & Thomas E.D. (1974) Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 18, 295-304.
12. Godfrey W.R., Ge Y.G., Spoden D.J., Levine B.L., June C.H., Blazar B.R. & Porter S.B. (2004) In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures. Blood 104, 453-461.
13. Goerner M., Gooley T., Flowers M.E., Sullivan K.M., Kiem H.P., Sanders J.E., Martin P.J. & Storb R. (2002) Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemias. Biology of Blood and Marrow Transplantation 8, 47-56.
14. Gregori S., Casorati M., Amuchastegui S., Smiroldo S., Davalli A.M. & Adorini L. (2001) Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. Journal of Immunology 167, 1945-1953.
15. Hoffmann P., Ermann J., Edinger M., Fathman C.G. & Strober S. (2002) Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. Journal of Experimental Medicine 196, 389-399.
16. Hoffmann P., Eder R., Kunz-Schughart L.A., Andreesen R. & Edinger M. (2004) Large-scale in vitro expansion of polyclonal human CD4(+)CD25high regulatory T cells. Blood 104, 895-903.
17. Karagiannidis C., Akdis M., Holopainen P., Woolley N.J., Hense G., Ruckert B., Mantel P.Y., Menz G., Akdis C.A., Blaser K. & Schmidt-Weber C.B. (2004) Glucocorticoids upregulate FOXP3 expression and regulatory T cells in asthma. Journal of Allergy and Clinical Immunology 114, 1425-1433.
18. + regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease. Journal of Immunotherapy 29, 336-349.
19. Liyanage U.K., Moore T.T., Joo H.G., Tanaka Y., Herrmann V., Doherty G., Drebin J.A., Strasberg S.M., Eberlein T.J., Goedegebuure P.S. & Linehan D.C. (2003) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. Journal of Immunology 169, 2756-2761.
20. Luft T., Moos M., Goldschmidt H., Ho A.D. & Gorner M. (2003) Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma. British Journal of Haematology 123, 646-653.
21. Miura Y., Thoburn C.J., Bright E.C., Phelps M.L., Shin T., Matsui E.C., Matsui W.H., Arai S., Fuchs E.J., Vogelsang G.B., Jones R.J., & Hess A.D. (2004) Association of Foxp3 regulatory gene expression with graft-versus-host disease. Blood 104, 2187-2193.
22. + regulatory T cells. Journal of Immunology 170, 3939-3943.
23. + immunoregulatory cells. Journal of Immunology 167, 1137-1140.
24. + regulatory T cell compartment. Journal of Immunology 173, 2227-2230.
25. Sakaguchi S., Sakaguchi N., Asano M., Itoh M. & Toda M. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. Journal of Immunology 155, 1151-1164.
26. + (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation. British Journal of Haematology 126, 697-703.
27. + regulatory T cells in patients with gastrointestinal malignancies: possible involvement of regulatory T cells in disease progression. Cancer 98, 1089-1099.
28. + suppressor T cells. Immunological Reviews 182, 58-67.
29. + T cells: a commonbasis between tumor immunity and autoimmunity. Journal of Immunology 163, 5211-5218.
30. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells. Journal of Immunology 160, 1212-1218.
31. Taylor P.A., Lees C.J. & Blazar B.R. (2002) The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493-3499.
32. +CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells. Journal of Immunology 173, 1444-1453.
33. Vogelsang G.B., Lee L. & Bensen-Kennedy D.M. (2003) Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant. Annual Review of Medicine 54, 29-52.
34. Wahl S.M., Wen J. & Moutsopoulos N.M. (2006) The kiss of death: interrupted by NK-cell close encounters of another kind. Trends in Immunology 27, 161-164.
35. Wolf A.M., Wolf D., Steurer M., Gastl G., Gunsilius E. & Grubeck-Loebenstein B. (2003) Increase of regulatory T cells in the peripheral blood of cancer patients. Clinical Cancer Research 9, 606-612.
36. Woo E.Y., Chu C.S., Goletz T.J., Schlienger K., Yeh H., Coukos G., Rubin S.C., Kaiser L.R. & June C.H. (2001) Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Research 61, 4766-4772.
37. - precursors. Journal of Immunology 169, 4183-4189.
38. + regulatory T cells in patients with chronic graft-versus-host disease. Blood 106, 2903-2911.